The author of Fortune's Theranos cover story now says the company 'misled' him
Essentially, the conversation had a number of nuances that had been boiled down to the idea that all 200 tests offered by Theranos at print time could be run using the nanotainers. From the time Parloff started his reporting to the time the article ran, the number of tests Theranos offered jumped from 100 to more than 200, which Parloff said he assumed meant that the nanotainer technology was being used on all of them.But while he was reporting, Parloff also heard rumors from people who had went to Theranos Wellness Centers, where the tests are administered, that they were disappointed to find out that they were getting regular blood tests, not finger-prick tests as they had assumed.And Theranos' answers had reinforced that simplification, Parloff said. But in reality, the situation was a lot more complex than that, involving other tests using other (still less-invasive methods). Those involved something called venipuncture, a way of taking a blood sample that's less painful than a normal venous draw and requires less blood.
"As much as I'd like to say that Holmes lied to me, I don't think she did. I do believe I was misled - intentionally - but I was also culpable, in that I failed to probe certain exasperatingly opaque answers that I repeatedly received."
- Cannes Lions 2021: On Day 3, Dentsu Webchutney brings home 2 Silver Lions
- Best laptop for students in India in 2021
- Twitter rolls out new update for iOS allowing users to share tweets to Instagram stories
- If you are vaccinated, IndiGo Airlines is giving discounts on airfares
- Microsoft joins Apple in $2 Trillion Club